Fredun Pharmaceuticals Ltd — Important, 16-02-2026: Company Update

Fredun Pharmaceuticals shareholders have approved the appointment of Mrs. Pooja Narendra Sanghavi as a Non-Executive Independent Director for a five-year term, starting November 28, 2025, and concluding November 27, 2030. Mrs. Sanghavi brings extensive experience as a Company Secretary and Compliance Officer, with deep knowledge of corporate law, governance, and regulatory filings. Her appointment is expected to significantly strengthen the company's board with enhanced expertise in compliance and corporate oversight, benefiting all stakeholders. She is not related to any other director and is not debarred from holding the position.